Profile
Leonard W.
Seymour is the founder of Hybrid BioSystems Ltd. which was founded in 2001.
He held the title of Director in 2010.
Currently, he is the Head-Clinical Pharmacology at the University of Oxford and the President of the British Society for Gene & Stem Cell Therapy.
Leonard W. Seymour active positions
| Companies | Position | Start |
|---|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | 2009-12-03 |
British Society for Gene & Stem Cell Therapy | President | 2009-12-03 |
Former positions of Leonard W. Seymour
| Companies | Position | End |
|---|---|---|
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Develops gene therapy treatments for ovarian and prostate cancer | Founder | 2010-12-14 |
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 3 |
|---|---|
University of Oxford
University of Oxford Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Hybrid BioSystems Ltd.
Hybrid BioSystems Ltd. Miscellaneous Commercial ServicesCommercial Services Develops gene therapy treatments for ovarian and prostate cancer | Commercial Services |
British Society for Gene & Stem Cell Therapy |
- Stock Market
- Insiders
- Leonard W. Seymour
















